Flow resistance modulated aerosolized active agent delivery

Details Flow resistance modulated aerosolized active agent delivery Flow resistance modulated aerosolized active agent delivery

A - Human Necessities

61

M

A61M 15/00 (2006.01)

Patent

CA 2346791

The present invention is directed to methods and devices for delivering an active agent formulation to the lung of a human patient. The active agent formulation may be in dry powder form, it may be nebulized, or it may be in admixture with a propellant. The active agent formulation is delivered to a patient at a low inspiratory flow rate for an initial period of time to increase bioavailability of the active agent.

L'invention concerne des méthodes et des dispositifs, permettant d'administrer une formulation d'agent actif dans les poumons d'un patient. Cette formulation d'agent actif peut se présenter sous forme de poudre, peut être nébulisée, ou peut être associée dans un mélange à un agent de propulsion. La formulation d'agent actif est administrée à un patient selon un débit inspiratoire faible pendant une durée initiale, afin d'augmenter la biodisponibilité de l'agent actif.

Affiliated with

Also associated with

Rating

Flow resistance modulated aerosolized active agent delivery does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Flow resistance modulated aerosolized active agent delivery, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Flow resistance modulated aerosolized active agent delivery will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1805968